XAGEOTCSoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends December 31Also trades as XAGEW
Longevity Health Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.11+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $277.24K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.4649 (−80.59%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Longevity Health Holdings, Inc. grew revenue 60.3% to $1.69M over the twelve months to Jun 30, 2026. Free cash flow was -$3.34M.
Revenue
$1.69M
+60.3% vs. a year earlier
Operating income
-$5.79M
TTM Q2 2026
Free cash flow
-$3.34M
FY2025
EPS, diluted
-$3.51
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $277.24K
- P/E ratio
- –
- Price to sales
- 0.16
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1206.01%
Fundamentals
- Revenue
- $1.69M
- Net income
- -$6.83M
- EPS, diluted
- -$3.51
- Free cash flow
- -$3.34M
- Book value per share
- -$3.51
- Diluted shares
- 2M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$1.69M+60.3% YoY
Gross profit
$994.84K+64.6% YoY
Operating income
-$5.79M
Net income
-$6.83M
EPS, diluted
-$3.51
Free cash flow
–
Reported periodTrailing twelve months